


Searching News Database: amonafide
HSMN NewsFeed - 25 Aug 2015
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
HSMN NewsFeed - 20 Jul 2009
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and Chief Commercial Officer
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
HSMN NewsFeed - 2 Jun 2007
Xanthus Presents Phase 2 Data Showing Xanafide is Associated with Complete Remissions in Secondary AML
Xanthus Presents Phase 2 Data Showing Xanafide is Associated with Complete Remissions in Secondary AML
HSMN NewsFeed - 8 Jan 2007
Xanthus Receives Orphan Drug Designation of Xanafide for the Treatment Of AML
Xanthus Receives Orphan Drug Designation of Xanafide for the Treatment Of AML
Additional items found! 5
Members Archive contains
5 additional stories matching:
amonafide
(Password required)
amonafide
(Password required)
